| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.00084 |
1 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.00084 |
1 |
| mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.00058 |
1 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.0004 |
1 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.0002 |
1 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.00015 |
1 |
| mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.0001 |
1 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
8.7e-05 |
1 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-7.5e-05 |
1 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-4.8e-05 |
1 |